HCPCS Level II code A9294 represents a prescription digital therapeutic intervention delivering cognitive and/or behavioral therapy with biofeedback that is FDA-cleared and billed per course of treatment. As digital therapeutics gain traction, this code captures a growing category of non-drug, software-driven therapies intended for ambulatory or home-based use and prescribed by licensed clinicians. Nationally, recognition of FDA-cleared prescription digital therapeutics has implications for coverage policy, clinical pathways, and billing practices as payers evaluate clinical effectiveness and appropriate reimbursement.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code and its clinical context, summaries of payer coverage considerations, and benchmarks where available. The publication outlines policy developments affecting digital therapeutic coverage, practical billing considerations tied to course-based pricing, and the clinical indications commonly associated with cognitive and behavioral digital programs.

The content highlights what to expect when coding and submitting claims for prescription digital cognitive/behavioral therapy with biofeedback, including the code’s intended use, typical settings, and stakeholder perspectives. Data not provided in the input—such as specific modifiers, associated taxonomies, ICD-10 pairings, payer-specific reimbursement rates, and related codes—are noted as unavailable.